- Home
- News
- us virgislands
- patient database
Refine by
Patient Database Articles & Analysis
13 news found
Indication Expansion: The Cellworks Platform can potentially identify additional indications where an investigational drug may be effective by leveraging the Cellworks patient database of 100,000+ omics patient profiles and 1,800 oncology cell-lines to evaluate the efficacy of the agent in other indications. ...
Doctors save time because they no longer have to cross-reference separate databases. The patient spends less time in the chair because all aspects of the exam have been streamlined. ...
Particularly in comparison to a single biomarker test, the chance to comprehensively test and predict patient responses to a variety of treatments provides significant benefit to patients and doctors and ultimately delivers accurate decision support on the most effective treatment options.” The clinical interpretation will be supported by OncoDNA ...
THE OFFER WILL COME IN COMBINATION WITH ONCODNA’S DATA ANALYSIS AND CLINICAL INTERPRETATION TOOLS FOR THE RAPID ANALYSIS AND REPORTING OF A PATIENT’S TUMOR MOLECULAR PROFILE. ONCODEEP KIT IS AVAILABLE FOR EARLY ACCESS AND WILL BE COMMERCIALLY AVAILABLE BY THE END OF Q2 2022. ...
From completing more than 10,000 in-person patient assessments (hands-on functional medicine and genome-based patient assessments) and from its comparison of that database to 60 million patient records, MNH has created the world’s first functional genomic AI-based tool that delivers precision medical care, significantly ...
MOUNTAIN VIEW, Calif., January 13, 2022 – G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Wireless Patch System (WPS) for non-invasive myoelectric activity measurement. ...
AMICA is a downloadable database of annotated multi-omic immune cells that includes information about gene expression, proteins, T-cell and B-cell receptors for immune cells, clinical and/or lab data, and a downloadable artificial intelligence software platform designed for characterizing and analyzing immune cells, as well as analyzing the immune system. According to Immunai, ...
ByImmunai
“We chose them because their technologies solve important patient needs and have great market potential, and we think their teams can get the job done. ...
"We chose them because their technologies solve important patient needs and have great market potential, and we think their teams can get the job done. ...
“Our expansion into functional genomics will help our partners tackle their most pressing questions in therapy development and will ultimately improve the lives of many patients.” Dropprint’s own database of immune cells will be folded into AMICA, including samples taken from patients with cancer and autoimmune diseases. ...
ByImmunai
Dropprint Genomics, a Y Combinator-backed startup, has developed computational infrastructure to conduct single-cell sequencing at scale, developed proprietary methods for cost-effective processing of hundreds of patient samples, and built a large database of immune cells from autoimmune and cancer cohorts. These cells will be incorporated into Immunai’s ...
ByImmunai
The key aspect of the invention is that the individual patient strain data are compared regionally within the left ventricle of the heart to a “normal” patient SQuEEZ database that was compiled by the inventors. Using this database information, each patient-specific SQuEEZ value at each of the points ...
The doctor, who is present in a different location (maybe in a city), and the patient at the remote location, are connected to each other over a video conferencing link. ...